Health-care companies rose amid hopes about obesity drug sales.
Novo Nordisk shares rose by more than 5% after the Danish weight-loss drug maker said the Food and Drug Administration accepted a new drug application for a pill form of its popular Wegovy injection.
Shares of rival Eli Lilly, which is also racing to get oral varieties of its weight-loss drug to market, rose in sympathy.
The SPDR Select Sector Health Care exchange-traded fund rose by more than 1% and is now back in the green for the year to date.
Health insurer Cigna Group swung to a profit and logged higher revenue in the first quarter, prompting the company to raise its full-year outlook.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
May 02, 2025 16:47 ET (20:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.